SEASPINE ORTHOPEDICS CORPORATION

SEASPINE ORTHOPEDICS CORPORATION specializes in the design, development, and manufacturing of advanced orthopedic implants and surgical instrumentation for spinal and extremity applications. Leveraging precision engineering and biomaterial science, the company delivers clinically validated solutions including spinal fusion systems, trauma fixation devices, and biocompatible implants tailored for minimally invasive procedures. Their technical expertise spans titanium and PEEK polymer processing, surface texturing for osseointegration, and CAD/CAM-driven product development aligned with FDA 510(k) and premarket approval pathways. Differentiators include proprietary implant geometries, patient-specific instrumentation, and rigorous biocompatibility testing protocols compliant with ISO 13485 and ANSI/ASTM standards. Award history is not available to infer specific agency relationships or government procurement patterns. Consequently, no direct government contracting experience can be confirmed from the provided data. The company operates within NAICS 339112, which encompasses medical device manufacturing, specifically focusing on orthopedic and surgical implants. In practice, this translates to high-precision, regulated production of Class II and Class III medical devices under cGMP conditions, serving hospital systems and surgical centers through commercial channels rather than federal procurement. SEASPINE ORTHOPEDICS CORPORATION is structured as a 2L entity with its primary operations based in Carlsbad, California. The company holds no government certifications, including small business, HUBZone, or 8(a) status. Its market positioning is commercial, serving the broader healthcare sector through direct sales and distributor networks rather than federal contracts. Geographic presence is centered in Southern California, with no indication of federal facility-based operations or government-specific supply chain engagements.